At Unison, we are actively recruiting qualified participants for a study evaluating the efficacy of the world's first acne mRNA vaccine. If you are interested and available, and you meet the qualifications outlined below, please contact us today.
‍
‍Length of trial: Through approximately December 2027 (includes up to 3 vaccine doses and follow-up visits)
‍Age range: 18 - 45 years old.
‍Condition qualifications: Moderate-to-Severe Acne
‍Treatment: Be part of an innovative study testing the world's first acnee mRNA vaccine. This research explores how the immune system can help fight acne. Participants will receive up to three shots and have follow-up visits to check results and safety.

All of our clinical trials are free of cost. No medical insurance is necessary and you may be compensated for your participation.